The impact of metaphylaxis of kidney stone disease in the renal function at long term in active kidney stone formers patients
- PMID: 21858428
- DOI: 10.1007/s00240-011-0407-5
The impact of metaphylaxis of kidney stone disease in the renal function at long term in active kidney stone formers patients
Abstract
A total of 150 patients were included in the analysis. Through chart review, we estimated glomerular filtration rate in the first visit and, at least, 5 years later. All patients were divided into two groups: (1) metaphylaxis adherents (n = 74) and (2) metaphylaxis non-adherents (n = 76). We followed all patients for at least 5 years. The Scr percentage of patients and GFR <60 mL/min was compared between groups. Variables were compared between groups using t test, χ(2) tests, odds ratios with 95% confidence intervals. There were no differences at baseline between groups. After 5 years of follow-up, GFR was 77.9 mL/min in non-adherent-metaphylaxis group and in the adherent-metaphylaxis group was 87.3 mL/min, with p value of 0.02. After 5 years of follow-up, we had a GFR <60 mL/min in the adherent-metaphylaxis group (4.89 vs. 21.95%) with p value of 0.001 and OR = 5.36; IC-95% = 1.95-14.8. Metaphylaxis of kidney stone disease could prevent chronic kidney disease.
Similar articles
-
Contribution of stone size to chronic kidney disease in kidney stone formers.Int J Urol. 2015 Jan;22(1):104-8. doi: 10.1111/iju.12606. Epub 2014 Aug 28. Int J Urol. 2015. PMID: 25168662
-
Baseline chronic kidney disease does not predict long-term renal functional decline after percutaneous nephrolithotomy.Urolithiasis. 2019 Oct;47(5):449-453. doi: 10.1007/s00240-019-01113-5. Epub 2019 Feb 12. Urolithiasis. 2019. PMID: 30747239
-
[Economic aspects of evidence-based metaphylaxis].Urologe A. 2006 Nov;45(11):1406-9. doi: 10.1007/s00120-006-1220-6. Urologe A. 2006. PMID: 17063349 German.
-
[Evidence-based pharmacological metaphylaxis of stone disease].Urologe A. 2006 Nov;45(11):1399-400, 1402-5. doi: 10.1007/s00120-006-1235-z. Urologe A. 2006. PMID: 17119896 Review. German.
-
Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.Arch Ital Urol Androl. 2015 Jul 7;87(2):105-20. doi: 10.4081/aiua.2015.2.105. Arch Ital Urol Androl. 2015. PMID: 26150027 Review.
Cited by
-
Changes in urinary risk profile after short-term low sodium and low calcium diet in recurrent Swiss kidney stone formers.BMC Nephrol. 2017 Dec 4;18(1):349. doi: 10.1186/s12882-017-0755-7. BMC Nephrol. 2017. PMID: 29202723 Free PMC article.
-
Clinical and Functional Assessment of Digenicity in Renal Phosphate Wasting.Nutrients. 2023 Apr 26;15(9):2081. doi: 10.3390/nu15092081. Nutrients. 2023. PMID: 37432176 Free PMC article.
-
The efficacy of metaphylaxis in treatment of recurrent urolithiasis.J Med Life. 2017 Jul-Sep;10(3):188-193. J Med Life. 2017. PMID: 29075349 Free PMC article.
-
Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome?Urol Res. 2012 Apr;40(2):95-112. doi: 10.1007/s00240-011-0448-9. Epub 2012 Jan 4. Urol Res. 2012. PMID: 22213019 Free PMC article. Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources